Be careful how you interpret this news through the eyes of a bunch of uneducated posters who have no idea what they are talking about (misinterpretation)....CAUTION!!!
What was reported today is good for Keryx.....gives them a chance to develop Zerenex as a free-standing drug vs one that is bundled. Also if they accomplish doing that, they will be potentially much better positioned as to cost to the patient.
Read Bentsur's statement very carefully to ascertain what he is saying between the lines.
Also notice, he told us that topline results on Zerenex is not in yet!!
Anything can be looked at for solely for it's positive attributes, unfortunately for you I don't think it's that easy to fool investors here who have seen exactly how this company operates and the struggles it faces naturally due to government regulation.